Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Clover Health Investments Corp

Healthcare US CLOV

3.83USD
-0.16(4.01%)

Last update at 2026-06-05T20:19:00Z

Day Range

3.834.00
LowHigh

52 Week Range

1.583.92
LowHigh

Fundamentals

  • Previous Close 3.99
  • Market Cap1253.95M
  • Volume4750304
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-85.34300M
  • Revenue TTM1923.51M
  • Revenue Per Share TTM3.76
  • Gross Profit TTM 355.10M
  • Diluted EPS TTM-0.18

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -85.54900M -46.26600M -210.14800M -338.84400M -587.75600M
Minority interest - - - - -
Net income -85.54900M -43.00900M -213.36100M -305.40100M -604.66600M
Selling general administrative 176.32M 408.93M 440.25M 486.64M 445.75M
Selling and marketing expenses - - 258.30M - -
Gross profit 355.88M 364.80M 255.95M 22.73M -79.18200M
Reconciled depreciation 1.69M 1.33M 0.99M 1.19M 1.25M
Ebit -85.54900M -46.26600M -210.14100M -370.92400M -636.99200M
Ebitda -83.86300M -44.93500M -207.63200M -369.73700M -635.74600M
Depreciation and amortization 1.69M 1.33M 2.51M 1.19M 1.25M
Non operating income net other - - - - -
Operating income -85.52900M -45.74900M -205.32900M -370.92400M -636.99200M
Other operating expenses 2009.84M 1416.88M 1465.87M 3847.61M 2108.99M
Interest expense 0.00000M 0.00000M 0.00700M 1.36M 16.91M
Tax provision - - - - -
Interest income - - - - -
Net interest income 0.00000M 0.00000M -0.14600M -1.36300M -16.91000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - -208.54200M -33.44300M 16.91M
Total revenue 1924.31M 1371.13M 1260.54M 3476.69M 1472.00M
Total operating expenses 441.43M 410.55M 461.28M 393.66M 557.81M
Cost of revenue 1568.41M 1006.33M 1004.59M 3453.95M 1551.18M
Total other income expense net -0.02000M -0.51700M -4.81900M 32.08M 49.24M
Discontinued operations - - - - -
Net income from continuing ops -85.54900M -46.26600M -226.39200M -338.84400M -587.75600M
Net income applicable to common shares - - - -338.84400M -587.75600M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 541.01M 580.74M 570.67M 808.62M 950.80M
Intangible assets 2.99M 2.99M 2.99M - -
Earning assets - - - - -
Other current assets 53.77M 28.79M 1.40M 24.43M 52.95M
Total liab 232.31M 239.60M 284.28M 460.88M 411.49M
Total stockholder equity 308.70M 341.14M 286.39M 347.74M 539.32M
Deferred long term liab - - - - -
Other current liab 55.57M 178.95M 80.57M 406.38M 175.57M
Common stock 0.05M 0.05M 0.05M 0.05M 0.05M
Capital stock 0.05M 0.05M 0.05M 0.05M 0.05M
Retained earnings -2288.35200M -2202.80300M -2159.79400M -1955.58200M -1616.73800M
Other liab - - - 16.19M 14.10M
Good will - - 0.00000M - -
Other assets - - - 15.73M 950.80M
Cash 78.30M 194.54M 122.86M 103.79M 299.97M
Cash and equivalents - - - - -
Total current liabilities 208.82M 213.52M 261.12M 440.66M 372.62M
Current deferred revenue - - 141.69M - 165.87M
Net debt -78.30100M -194.54300M -118.20000M -97.93100M -272.14100M
Short term debt - - 1.67M 1.83M 3.06M
Short long term debt - - - - -
Short long term debt total - - 4.66M 5.86M 27.83M
Other stockholder equity 2596.48M 2545.48M 2132.31M 1917.58M 1541.91M
Property plant equipment - - - 9.78M 7.65M
Total current assets 307.86M 343.12M 427.97M 625.00M 752.55M
Long term investments 199.66M 216.06M 121.00M 138.11M 175.94M
Net tangible assets - - - 327.74M 404.15M
Short term investments 17.05M 27.00M 119.82M 230.97M 315.29M
Net receivables 158.74M 92.79M 113.83M 147.16M 62.32M
Long term debt - - - - 19.94M
Inventory - - 70.05M -101.88400M -153.91700M
Accounts payable 153.25M 34.56M 37.18M 32.45M 28.13M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.53M -1.58400M -2.37000M -9.37400M -1.93400M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 36.69M 27.60M 10.25M 15.73M 10.43M
Deferred long term asset charges - - - - -
Non current assets total 233.16M 237.62M 142.70M 183.62M 198.26M
Capital lease obligations - - 4.66M 5.86M 7.89M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 6.12M 0.56M 69.01M 95.13M -434.72400M
Change to liabilities - - - 7.63M 5.31M
Total cashflows from investing activities 4.08M 0.56M 140.01M 95.13M -435.44700M
Net borrowings - - 0.00000M - -30.92500M
Total cash from financing activities -53.38400M -17.36100M -33.86100M -4.96200M 925.39M
Change to operating activities - - - 98.71M 196.76M
Net income -85.54900M -43.00900M -213.36100M -338.84400M -587.75600M
Change in cash -116.24200M 18.05M -9.71900M -113.75500M 207.62M
Begin period cash flow 194.54M 176.49M 186.21M 299.97M 92.35M
End period cash flow 78.30M 194.54M 176.49M 186.21M 299.97M
Total cash from operating activities -66.93400M 34.84M -115.87100M -203.92600M -282.32600M
Issuance of capital stock 1.81M 0.90M 1.25M 1.40M 289.92M
Depreciation 1.69M 1.33M 2.51M 1.19M 1.25M
Other cashflows from investing activities - - - - -
Dividends paid - - - - 0.30M
Change to inventory - - -4.75400M - -
Change to account receivables - -6.55200M 4.75M -8.02900M -9.39100M
Sale purchase of stock -55.19800M -18.26300M -6.22000M -6.36200M -0.14700M
Other cashflows from financing activities -53.38400M -17.36100M -28.79100M 95.13M 666.85M
Change to netincome - - - 35.39M 97.83M
Capital expenditures 2.04M 1.56M 0.58M 4.47M 0.72M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -84.19700M 12.86M -55.43400M 98.31M 192.67M
Stock based compensation 103.66M 114.33M 140.93M 164.31M 163.72M
Other non cash items -2.53100M -50.66300M 9.48M -128.88900M 13.88M
Free cash flow -68.97700M 33.29M -116.45500M -208.39300M -283.04900M

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CLOV
Clover Health Investments Corp		 -0.16 4.01% 3.83 - 81.97 0.65 3.81 0.44 -0.6496
UNH
UnitedHealth Group Incorporated		 3.00 0.76% 399.47 22.57 18.38 1.33 5.65 1.38 13.97
CVS
CVS Health Corp		 1.11 1.17% 95.93 55.65 10.80 0.25 1.32 0.42 17.09
CI
Cigna Corp		 8.80 3.14% 289.48 12.47 9.12 0.27 1.75 0.35
ELV
Elevance Health Inc		 6.09 1.49% 415.53 13.02 12.47 0.36 1.60 0.47

Reports Covered

Stock Research & News

View All

Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

Clover Health Investments Corp

1209 Orange Street, Wilmington, DE, United States, 19801

Key Executives

Name Title Year Born
Mr. Vivek Garipalli Co-Founder, CEO & Chairman of Directors 1979
Mr. Andrew Toy Co-Founder, Pres, & Director 1979
Ms. Jamie L. Reynoso Chief Operating Officer 1970
Mr. Prabhdeep Singh Chief Growth Officer 1985
Mr. Scott J. Leffler Chief Financial Officer 1975
Mr. Conrad Wai Chief Technology Officer NA
Mr. Derrick L. Nueman Head of Investor Relations & Corp. strategy NA
Ms. Wendy Richey Chief Compliance Officer NA
Mr. Joseph Richards Martin Gen. Counsel & Corp. Sec. 1977
Ms. Rachel Fish Chief People Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.